Annual Net Income
-$1.18 M
+$363.00 K+23.51%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual net profit is -$1.18 million, with the most recent change of +$363.00 thousand (+23.51%) on December 31, 2023.
- During the last 3 years, MACK annual net income has risen by +$1.85 million (+61.00%).
Performance
MACK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Income
$201.37 M
+$201.61 M+84004.17%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly net profit is $201.37 million, with the most recent change of +$201.61 million (+84004.17%) on March 1, 2024.
- Over the past year, MACK quarterly net income has increased by +$201.65 million (+72275.63%).
Performance
MACK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
$200.46 M
+$201.64 M+17073.75%
March 1, 2024
Summary
- As of February 10, 2025, MACK TTM net profit is $200.46 million, with the most recent change of +$201.64 million (+17073.75%) on March 1, 2024.
- Over the past year, MACK TTM net income has increased by +$201.89 million (+14088.83%).
Performance
MACK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MACK Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.5% | +10000.0% | +10000.0% |
| 3 y3 years | +61.0% | +10000.0% | +10000.0% |
| 5 y5 years | +97.1% | +10000.0% | +10000.0% |
MACK Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.9% | at high | -100.2% | at high | -101.2% |
| 5 y | 5-year | at high | +1367.6% | at high | -100.6% | at high | -108.6% |
| alltime | all time | -100.3% | >+9999.0% | -60.6% | -125.2% | -58.6% | -189.6% |
Merrimack Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $201.37 M(<-9900.0%) | $200.46 M(<-9900.0%) |
| Dec 2023 | -$1.18 M(-23.5%) | -$240.00 K(-14.0%) | -$1.18 M(-17.6%) |
| Sep 2023 | - | -$279.00 K(-28.6%) | -$1.43 M(-10.2%) |
| Jun 2023 | - | -$391.00 K(+44.3%) | -$1.60 M(-5.2%) |
| Mar 2023 | - | -$271.00 K(-44.9%) | -$1.68 M(+9.0%) |
| Dec 2022 | -$1.54 M(-37.1%) | -$492.00 K(+11.3%) | -$1.54 M(+1.1%) |
| Sep 2022 | - | -$442.00 K(-7.5%) | -$1.53 M(-5.2%) |
| Jun 2022 | - | -$478.00 K(+262.1%) | -$1.61 M(-14.9%) |
| Mar 2022 | - | -$132.00 K(-72.2%) | -$1.89 M(-23.0%) |
| Dec 2021 | -$2.46 M(-18.9%) | -$475.00 K(-9.5%) | -$2.46 M(-20.5%) |
| Sep 2021 | - | -$525.00 K(-30.8%) | -$3.09 M(-13.5%) |
| Jun 2021 | - | -$759.00 K(+9.1%) | -$3.57 M(-10.2%) |
| Mar 2021 | - | -$696.00 K(-37.2%) | -$3.97 M(+31.2%) |
| Dec 2020 | -$3.03 M(-82.5%) | -$1.11 M(+10.1%) | -$3.03 M(-325.8%) |
| Sep 2020 | - | -$1.01 M(-13.5%) | $1.34 M(-18.3%) |
| Jun 2020 | - | -$1.16 M(-567.1%) | $1.64 M(-124.8%) |
| Mar 2020 | - | $249.00 K(-92.4%) | -$6.63 M(-61.8%) |
| Dec 2019 | -$17.33 M(-57.2%) | $3.26 M(-562.6%) | -$17.33 M(-41.3%) |
| Sep 2019 | - | -$705.00 K(-92.5%) | -$29.54 M(+18.9%) |
| Jun 2019 | - | -$9.43 M(-9.8%) | -$24.84 M(-25.1%) |
| Mar 2019 | - | -$10.46 M(+16.9%) | -$33.18 M(-18.1%) |
| Dec 2018 | -$40.51 M(-108.6%) | -$8.94 M(-324.2%) | -$40.51 M(-9.0%) |
| Sep 2018 | - | $3.99 M(-122.4%) | -$44.51 M(-2.0%) |
| Jun 2018 | - | -$17.77 M(-0.1%) | -$45.40 M(-109.4%) |
| Mar 2018 | - | -$17.78 M(+37.3%) | $483.93 M(+2.5%) |
| Dec 2017 | $472.03 M(-411.1%) | -$12.95 M(-517.5%) | $472.03 M(+4.3%) |
| Sep 2017 | - | $3.10 M(-99.4%) | $452.53 M(+7.9%) |
| Jun 2017 | - | $511.56 M(-1823.2%) | $419.36 M(-393.4%) |
| Mar 2017 | - | -$29.69 M(-8.5%) | -$142.95 M(-5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$151.74 M(+2.6%) | -$32.45 M(+7.9%) | -$151.74 M(-9.2%) |
| Sep 2016 | - | -$30.07 M(-40.8%) | -$167.12 M(-7.0%) |
| Jun 2016 | - | -$50.75 M(+31.9%) | -$179.64 M(+18.4%) |
| Mar 2016 | - | -$38.47 M(-19.6%) | -$151.67 M(+2.5%) |
| Dec 2015 | -$147.96 M(+77.6%) | -$47.83 M(+12.3%) | -$147.96 M(+34.7%) |
| Sep 2015 | - | -$42.59 M(+87.0%) | -$109.83 M(+15.4%) |
| Jun 2015 | - | -$22.78 M(-34.5%) | -$95.13 M(+5.2%) |
| Mar 2015 | - | -$34.76 M(+258.5%) | -$90.47 M(+8.6%) |
| Dec 2014 | -$83.29 M(-36.4%) | -$9.70 M(-65.2%) | -$83.29 M(-21.9%) |
| Sep 2014 | - | -$27.90 M(+54.1%) | -$106.65 M(-9.9%) |
| Jun 2014 | - | -$18.11 M(-34.4%) | -$118.38 M(-9.2%) |
| Mar 2014 | - | -$27.59 M(-16.6%) | -$130.36 M(-0.4%) |
| Dec 2013 | -$130.93 M(+43.4%) | -$33.06 M(-16.6%) | -$130.93 M(+6.8%) |
| Sep 2013 | - | -$39.63 M(+31.7%) | -$122.63 M(+15.5%) |
| Jun 2013 | - | -$30.08 M(+6.9%) | -$106.20 M(+10.5%) |
| Mar 2013 | - | -$28.15 M(+13.7%) | -$96.15 M(+5.3%) |
| Dec 2012 | -$91.28 M(+15.2%) | -$24.77 M(+6.8%) | -$91.28 M(+7.9%) |
| Sep 2012 | - | -$23.20 M(+15.8%) | -$84.63 M(+5.7%) |
| Jun 2012 | - | -$20.03 M(-14.0%) | -$80.03 M(-10.1%) |
| Mar 2012 | - | -$23.28 M(+28.5%) | -$89.05 M(+12.4%) |
| Dec 2011 | -$79.22 M(+58.1%) | -$18.12 M(-2.6%) | -$79.22 M(+11.3%) |
| Sep 2011 | - | -$18.60 M(-36.0%) | -$71.20 M(+7.4%) |
| Jun 2011 | - | -$29.05 M(+115.9%) | -$66.30 M(+31.3%) |
| Mar 2011 | - | -$13.46 M(+33.3%) | -$50.50 M(+0.8%) |
| Dec 2010 | -$50.10 M(+2.1%) | -$10.10 M(-26.3%) | -$50.10 M(+25.2%) |
| Sep 2010 | - | -$13.70 M(+3.4%) | -$40.01 M(+52.1%) |
| Jun 2010 | - | -$13.25 M(+1.4%) | -$26.31 M(+101.4%) |
| Mar 2010 | - | -$13.06 M | -$13.06 M |
| Dec 2009 | -$49.07 M | - | - |
FAQ
- What is Merrimack Pharmaceuticals annual net profit?
- What is the all time high annual net income for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual net income year-on-year change?
- What is Merrimack Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly net income year-on-year change?
- What is Merrimack Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals TTM net income year-on-year change?
What is Merrimack Pharmaceuticals annual net profit?
The current annual net income of MACK is -$1.18 M
What is the all time high annual net income for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual net profit is $472.03 M
What is Merrimack Pharmaceuticals annual net income year-on-year change?
Over the past year, MACK annual net profit has changed by +$363.00 K (+23.51%)
What is Merrimack Pharmaceuticals quarterly net profit?
The current quarterly net income of MACK is $201.37 M
What is the all time high quarterly net income for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly net profit is $511.56 M
What is Merrimack Pharmaceuticals quarterly net income year-on-year change?
Over the past year, MACK quarterly net profit has changed by +$201.65 M (+72275.63%)
What is Merrimack Pharmaceuticals TTM net profit?
The current TTM net income of MACK is $200.46 M
What is the all time high TTM net income for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high TTM net profit is $483.93 M
What is Merrimack Pharmaceuticals TTM net income year-on-year change?
Over the past year, MACK TTM net profit has changed by +$201.89 M (+14088.83%)